首页> 外国专利> Chimeric interleukin-6 soluble receptor/interleukin-6 fusion protein (sIL-6R/IL-6) to treat malignant melanoma cells

Chimeric interleukin-6 soluble receptor/interleukin-6 fusion protein (sIL-6R/IL-6) to treat malignant melanoma cells

机译:嵌合白介素-6可溶性受体/白介素6融合蛋白(sIL-6R / IL-6)治疗恶性黑色素瘤细胞

摘要

Described are chimeric proteins constructed from the fusion of the naturally occurring form of the soluble IL-6 receptor and the naturally occurring form of IL-6. These proteins are useful for treatment of cancer and liver disorders, enhancement of bone marrow transplantation, and treatment of other IL-6 related conditions.
机译:描述了由可溶性IL-6受体的天然存在形式和IL-6天然存在形式的融合构建的嵌合蛋白。这些蛋白质可用于治疗癌症和肝脏疾病,增强骨髓移植以及治疗其他与IL-6相关的疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号